Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-665-7 | CAS number: 7681-38-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- other information
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: The report is incomplete and unsigned. Lab and authors are unknown and there is no quality control. Individual data are not shown.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 976
Materials and methods
- Type of sensitisation studied:
- skin
- Study type:
- study with volunteers
- Principles of method if other than guideline:
- Patch Test
- GLP compliance:
- no
Test material
- Reference substance name:
- bath salt crystals containing 80.8 % sodium sulfate
- IUPAC Name:
- bath salt crystals containing 80.8 % sodium sulfate
- Details on test material:
- Bath salt crystals allegedly containing 80.8% sodium sulfate.
Constituent 1
Method
- Type of population:
- general
- Subjects:
- - Number of subjects exposed: 56 males and 5 females
- Age: 16-70 - Route of administration:
- dermal
- Details on study design:
- - Study type: Patch test.
- Preparation of test substance for induction: A 1.25% aqueous solution was prepared. This concentration represents a 100 fold increase of the normal use level.
- Induction schedule: Subjects were exposed on their backs. The test patch unit consited of a strip of two-inch wide blenderm surgical tape with two rows of five 12.7 mm filter paper discs each. The first application lasted for 48 hours. All other inductions were for 24 hours. Reactions tohe initial site were scored 48 and 96 hours after patch removal. 8 other 24 hour inductions were done on mondays, Wednesdays and Fridays (3.5 weeks)on 3 alternate sites (unless the reaction or tape irritation was severe than other sites were used). Reactions were recorded 3-9 hours before application and 24 hours after patch removal.
- Concentrations used for induction: 1.25% aqueous solution.
- Concentration in Freuds Complete Adjuvant (FCA): -
- Challenge schedule: On monday in week 7 subjects were challenged on a previously unpatched site. After 48 hours the patches were removed. The patches were scored 48 hours 48 following removal.
- Concentrations used for challenge: 1.25% aqueous solution.
- Rechallenge: subjects that showed signs of sentisation in the challenge phase were tested again after a 2 week rest period. At the original concentration under occlusion, in a dilution of original strenght (1:3) under occlusion, as used in practice (subject applied the project to the flex part of the arm 3 times/day for 5 days.
EXAMINATIONS
- Grading system: patch reactions were scored by experienced technitians. According to the following scoring system:
0 No evidence of any effect +/- Barely perceptible. Minimal faint unifrom spotty erythema.
1 Mild. Pink unifrom erythema covering most of the contact site.
2 Moderate. Pink-red erythema visibly uniform in the whole contact site.
3 Marked. Bright red erythrema with accompanying edema, petechiae or papules.
4 Severe. Deep red erythema with vesiculation or weeping with or without edema.
- Pilot study: -
Results and discussion
- Results of examinations:
- RESULTS OF PILOT STUDY: -
RESULTS OF TEST
- Sensitization reaction: One subject showed a score 1 reaction during the induction period. Other subjects did not react to the application (data not shown).
- Clinical signs: Mild. Pink unifrom erythema covering most of the contact site.
- Rechallenge: Data not shown.
Applicant's summary and conclusion
- Conclusions:
- Classification: not sensitizing
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.